The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Expansion Is Expected For The Pergonal Market Over The Forecast Period?
The growth observed in the historic period stems from a rise in infertility cases among women, a growing understanding of available fertility treatment options, the expansion of clinical gynecology services, increased availability of hormone-based infertility drugs, and a trend towards rising maternal ages.
Anticipated expansion during the forecast period is fueled by a heightened demand for assisted reproductive technologies, increasing investments in fertility care infrastructure, an escalating emphasis on personalized hormone dosing, broader accessibility of fertility treatments in emerging markets, and advancing clinical research in reproductive endocrinology.
Key developments expected throughout the forecast period include a growing uptake of hormonal fertility therapies, an increasing need for assisted reproductive treatments, wider utilization of urine-derived gonadotropins, an expansion of specialized fertility clinics, and a sharpened focus on personalized ovulation induction protocols.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20180&type=smp
Which Core Factors Are Supporting The Expansion Of The Pergonal Market?
The pergonal market is anticipated to expand due to the rising occurrence of infertility. Infertility denotes the incapacity to achieve or sustain a pregnancy to full term. This increase in infertility stems from various factors, including postponing childbearing, specific lifestyle choices, exposure to environmental pollutants, and a higher incidence of medical conditions like polycystic ovary syndrome (PCOS) and endometriosis. Pergonal assists infertile patients by stimulating ovulation, leveraging its blend of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to encourage egg development in women experiencing ovulatory issues. For example, in April 2023, the World Health Organization, an intergovernmental body based in Switzerland, reported that roughly 17.5% of the worldwide adult population, equivalent to about 1 in 6 people, encounters infertility. Consequently, the growing incidence of infertility is fueling the expansion of the pergonal market. The expanding embrace of in vitro fertilization (IVF) procedures is anticipated to drive future growth in the pergonal market. IVF procedures are medical interventions designed to aid individuals or couples in achieving pregnancy by fertilizing an egg with sperm externally before implanting the resulting embryo into the womb. The uptake of IVF is rising as more individuals postpone parenthood for professional, academic, or social reasons, leading to age-related fertility decline and an increased dependence on fertility interventions. Pergonal facilitates IVF procedures by prompting the ovaries to generate numerous mature eggs, thereby enhancing the probability of successful fertilization and embryo formation. For instance, in June 2025, the Human Fertilisation & Embryology Authority, the UK’s independent fertility treatment regulator, stated that in 2023, 52,400 patients underwent more than 77,500 in vitro fertilization (IVF) cycles at accredited fertility clinics across the UK. Furthermore, egg freezing cycles grew from 4,700 in 2022 to 6,900 in 2023, constituting 7% of all cycles. Consequently, the growing adoption of IVF procedures is propelling the pergonal market.
Which Segment Divisions Form The Structure Of The Pergonal Market?
The pergonal market covered in this report is segmented –
1) By Indication: Infertility Treatment, Hypogonadism, Ovarian Stimulation
2) By Distribution Channel: Pharmacies, Online Pharmacies
3) By End User: Hospitals, Fertility Clinics, Home Care
Who Are The Companies Shaping The Pergonal Market Landscape?
Major companies operating in the pergonal market are Merck KGaA
Access The Complete Pergonal Market Report:
https://www.thebusinessresearchcompany.com/report/pergonal-global-market-report
Which Region Contributes The Most To The Pergonal Market?
North America was the largest region in the pergonal market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pergonal market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model